(Q46954815)

26 December 2017

title

2MD, a new anabolic agent for osteoporosis treatment (English)

1 reference

26 December 2017

0 references

L A Plum

1

1 reference

26 December 2017

L A Fitzpatrick

2

1 reference

26 December 2017

X Ma

3

1 reference

26 December 2017

N C Binkley

4

1 reference

26 December 2017

J B Zella

5

1 reference

26 December 2017

M Clagett-Dame

6

1 reference

26 December 2017

H F DeLuca

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

21 February 2006

1 reference

26 December 2017

Osteoporosis International

published in

1 reference

26 December 2017

volume

17

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

704-715

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-005-0036-3

exact match

0 references

cites work

Calcitriol treatment is not effective in postmenopausal osteoporosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-005-0036-3

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

21 January 2018

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

1 reference

12 December 2020

Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3

1 reference

12 December 2020

Biological activity of 25-hydroxyergocalciferol in rats.

1 reference

12 December 2020

Calcitriol in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Restoration of bone mass in the severely osteopenic senescent rat.

1 reference

12 December 2020

Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats

1 reference

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

12 December 2020

Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats

1 reference

12 December 2020

Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis.

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

Can the fast bone loss in osteoporotic and osteopenic patients be stopped with active vitamin D metabolites?

1 reference

12 December 2020

New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

12 December 2020

Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide

1 reference

12 December 2020

Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate

1 reference

12 December 2020

A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation

1 reference

12 December 2020

A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures

1 reference

12 December 2020

Negative regulatory elements in the human parathyroid hormone gene

1 reference

12 December 2020

Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

1 reference

12 December 2020

Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.

1 reference

12 December 2020

2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts

1 reference

12 December 2020

Long-term treatment with calcitriol in postmenopausal osteoporosis

1 reference

12 December 2020

Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene

1 reference

12 December 2020

Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S00198-005-0036-3

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017